Loading…
To provide $30,000,000 in funding to the Department of Education to provide assistance to public school districts for the prevention of drug resistant infections.
Legislative Progress
Introduced
December 11, 2007
Latest Action
December 11, 2007
Primary Sponsor
Edolphus TownsDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2008 · fourth_quarter · Health Issues
Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act H.R. 1424, Emergency Economic Stabilization Act of 2008 H Res. 988, Designating the month of March 2008 as `MRSA Awareness Month' S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision) S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Pharmacy
Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision)
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Health Issues
Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act H.R. 1424, Emergency Economic Stabilization Act of 2008 H Res. 988, Designating the month of March 2008 as `MRSA Awareness Month' S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision) S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Pharmacy
Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision)
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · second_quarter · Pharmacy
Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · second_quarter · Health Issues
Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · second_quarter · Pharmacy
Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act
Client expense: $125,920 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · second_quarter · Health Issues
Medical Research Antibiotic Resistance Issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month"
Client expense: $125,920 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · first_quarter · Medical/Disease Research/Clinical Labs
H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4352, To provide $30,000,000 in funding to the Department of Education to provide assistance to public school districts for the prevention of drug resistant infections, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention
Client expense: $250,000 · Firm income: Not reported
2008 · first_quarter · Pharmacy
Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · first_quarter · Health Issues
Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · first_quarter · Pharmacy
Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act H.R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H.R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act
Client expense: $131,330 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2008 · first_quarter · Health Issues
Medical Research Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act H.R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H.R. 4451, MRSA Research & Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S 2526, Worker Infection Protection Act
Client expense: $131,330 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE